Codexis (CDXS) EBITDA (2010 - 2026)
Codexis (CDXS) recorded quarterly EBITDA of -$8.0 million in Q1 2026, down 176.17% quarter-over-quarter from $10.6 million in Q4 2025, and up 60.74% on a YoY basis from -$5.0 million in Q1 2025.
Codexis (CDXS) EBITDA (2010 - 2026) Analysis & Trends
Codexis' EBITDA history runs 17 years deep, the most recent figure standing at -$8.0 million for Q1 2026.
- In Q1 2026, EBITDA rose 60.74% year-over-year to -$8.0 million; the TTM figure through Mar 2026 stood at -$29.3 million (up 56.35% YoY), while the FY2025 annual figure was -$41.7 million, up 28.67% from the prior year.
- EBITDA was -$8.0 million for Q1 2026 at Codexis, down from $10.6 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $10.6 million in Q4 2025 to a low of -$32.1 million in Q3 2023.
- Historically, EBITDA has averaged -$12.4 million across 5 years, with a median of -$12.6 million in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 2712.46% in 2024, then soared 243.84% in 2025.
- A 5-year view of EBITDA shows it stood at -$13.2 million in 2022, then soared by 102.12% to $281000.0 in 2023, then sank by 2712.46% to -$7.3 million in 2024, then jumped by 243.84% to $10.6 million in 2025, then tumbled by 176.17% to -$8.0 million in 2026.
- The last three EBITDA figures came in at -$8.0 million (Q1 2026), $10.6 million (Q4 2025), and -$18.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | -8.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.04 Mn |
| Dec 31, 2025 | 10.56 Mn |
| Sep 30, 2025 | -18.95 Mn |
| Jun 30, 2025 | -12.86 Mn |
| Mar 31, 2025 | -20.49 Mn |
| Dec 31, 2024 | -7.34 Mn |
| Sep 30, 2024 | -16.56 Mn |
| Jun 30, 2024 | -22.73 Mn |
| Mar 31, 2024 | -11.89 Mn |
| Dec 31, 2023 | 281,000.00 |
| Sep 30, 2023 | -32.06 Mn |
| Jun 30, 2023 | -12.63 Mn |
| Mar 31, 2023 | -23.67 Mn |
| Dec 31, 2022 | -13.25 Mn |
| Sep 30, 2022 | -10.64 Mn |
| Jun 30, 2022 | -2.61 Mn |
| Mar 31, 2022 | -8.39 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | -4.49 Mn |